Exemestane Versus Anastrozole in Postmenopausal Women With Early Breast Cancer: NCIC CTG MA.27—A Randomized Controlled Phase III Trial

PURPOSE: In patients with hormone-dependent postmenopausal breast cancer, standard adjuvant therapy involves 5 years of the nonsteroidal aromatase inhibitors anastrozole and letrozole. The steroidal inhibitor exemestane is partially non–cross-resistant with nonsteroidal aromatase inhibitors and is a...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Goss, Paul E., Ingle, James N., Pritchard, Kathleen I., Ellis, Matthew J., Sledge, George W., Budd, G. Thomas, Rabaglio, Manuela, Ansari, Rafat H., Johnson, David B., Tozer, Richard, D'Souza, David P., Chalchal, Haji, Spadafora, Silvana, Stearns, Vered, Perez, Edith A., Liedke, Pedro E.R., Lang, Istvan, Elliott, Catherine, Gelmon, Karen A., Chapman, Judy-Anne W., Shepherd, Lois E.
Format: Artigo
Sprog:Inglês
Udgivet: American Society of Clinical Oncology 2013
Fag:
ORIGINAL REPORTS
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3612593/
https://ncbi.nlm.nih.gov/pubmed/23358971
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2012.44.7805
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker